SLC9B1 methylation predicts fetal intolerance of labor

Anna K. Knight, Karen N. Conneely, Varun Kilaru, Dawayland Cobb, Jennifer Payne, Samantha Meilman, Elizabeth J. Corwin, Zachary A Kaminsky, Anne L. Dunlop, Alicia K. Smith

Research output: Contribution to journalArticle

Abstract

Fetal intolerance of labor is a common indication for delivery by Caesarean section. Diagnosis is based on the presence of category III fetal heart rate tracing, which is an abnormal heart tracing associated with increased likelihood of fetal hypoxia and metabolic acidemia. This study analyzed data from 177 unique women who, during their prenatal visits (7-15 weeks and/or 24–32 weeks) to Atlanta area prenatal care clinics, consented to provide blood samples for DNA methylation (HumanMethylation450 BeadChip) and gene expression (Human HT-12 v4 Expression BeadChip) analyses. We focused on 57 women aged 18–36 (mean 25.4), who had DNA methylation data available from their second prenatal visit. DNA methylation patterns at CpG sites across the genome were interrogated for associations with fetal intolerance of labor. Four CpG sites (P value <8.9 × 10−9, FDR <0.05) in gene SLC9B1, a Na+/H+ exchanger, were associated with fetal intolerance of labor. DNA methylation and gene expression were negatively associated when examined longitudinally during pregnancy using a linear mixed-effects model. Positive predictive values of methylation of these four sites ranged from 0.80 to 0.89, while negative predictive values ranged from 0.91 to 0.92. The four CpG sites were also associated with fetal intolerance of labor in an independent cohort (the Johns Hopkins Prospective PPD cohort). Therefore, fetal intolerance of labor could be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation. Fetal intolerance of labor may be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation by assessing DNA methylation patterns of SLC9B1. The identification of pregnant women at elevated risk for fetal intolerance of labor may allow for the development of targeted treatments or management plans.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalEpigenetics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

DNA Methylation
Methylation
Pregnancy
Mothers
Fetal Hypoxia
Gene Expression
Sodium-Hydrogen Antiporter
Fetal Heart Rate
Prenatal Care
Tuberculin
Cesarean Section
Pregnant Women
Genome
Genes

Keywords

  • Biomarker, complication
  • delivery
  • fetal distress; NHEDC1; pregnancy; SLC9B1; sodium hydrogen exchanger

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Knight, A. K., Conneely, K. N., Kilaru, V., Cobb, D., Payne, J., Meilman, S., ... Smith, A. K. (Accepted/In press). SLC9B1 methylation predicts fetal intolerance of labor. Epigenetics, 1-7. https://doi.org/10.1080/15592294.2017.1411444

SLC9B1 methylation predicts fetal intolerance of labor. / Knight, Anna K.; Conneely, Karen N.; Kilaru, Varun; Cobb, Dawayland; Payne, Jennifer; Meilman, Samantha; Corwin, Elizabeth J.; Kaminsky, Zachary A; Dunlop, Anne L.; Smith, Alicia K.

In: Epigenetics, 01.01.2018, p. 1-7.

Research output: Contribution to journalArticle

Knight, AK, Conneely, KN, Kilaru, V, Cobb, D, Payne, J, Meilman, S, Corwin, EJ, Kaminsky, ZA, Dunlop, AL & Smith, AK 2018, 'SLC9B1 methylation predicts fetal intolerance of labor', Epigenetics, pp. 1-7. https://doi.org/10.1080/15592294.2017.1411444
Knight, Anna K. ; Conneely, Karen N. ; Kilaru, Varun ; Cobb, Dawayland ; Payne, Jennifer ; Meilman, Samantha ; Corwin, Elizabeth J. ; Kaminsky, Zachary A ; Dunlop, Anne L. ; Smith, Alicia K. / SLC9B1 methylation predicts fetal intolerance of labor. In: Epigenetics. 2018 ; pp. 1-7.
@article{c645049adb1b48f1985b09bf7439c3bf,
title = "SLC9B1 methylation predicts fetal intolerance of labor",
abstract = "Fetal intolerance of labor is a common indication for delivery by Caesarean section. Diagnosis is based on the presence of category III fetal heart rate tracing, which is an abnormal heart tracing associated with increased likelihood of fetal hypoxia and metabolic acidemia. This study analyzed data from 177 unique women who, during their prenatal visits (7-15 weeks and/or 24–32 weeks) to Atlanta area prenatal care clinics, consented to provide blood samples for DNA methylation (HumanMethylation450 BeadChip) and gene expression (Human HT-12 v4 Expression BeadChip) analyses. We focused on 57 women aged 18–36 (mean 25.4), who had DNA methylation data available from their second prenatal visit. DNA methylation patterns at CpG sites across the genome were interrogated for associations with fetal intolerance of labor. Four CpG sites (P value <8.9 × 10−9, FDR <0.05) in gene SLC9B1, a Na+/H+ exchanger, were associated with fetal intolerance of labor. DNA methylation and gene expression were negatively associated when examined longitudinally during pregnancy using a linear mixed-effects model. Positive predictive values of methylation of these four sites ranged from 0.80 to 0.89, while negative predictive values ranged from 0.91 to 0.92. The four CpG sites were also associated with fetal intolerance of labor in an independent cohort (the Johns Hopkins Prospective PPD cohort). Therefore, fetal intolerance of labor could be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation. Fetal intolerance of labor may be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation by assessing DNA methylation patterns of SLC9B1. The identification of pregnant women at elevated risk for fetal intolerance of labor may allow for the development of targeted treatments or management plans.",
keywords = "Biomarker, complication, delivery, fetal distress; NHEDC1; pregnancy; SLC9B1; sodium hydrogen exchanger",
author = "Knight, {Anna K.} and Conneely, {Karen N.} and Varun Kilaru and Dawayland Cobb and Jennifer Payne and Samantha Meilman and Corwin, {Elizabeth J.} and Kaminsky, {Zachary A} and Dunlop, {Anne L.} and Smith, {Alicia K.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/15592294.2017.1411444",
language = "English (US)",
pages = "1--7",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - SLC9B1 methylation predicts fetal intolerance of labor

AU - Knight, Anna K.

AU - Conneely, Karen N.

AU - Kilaru, Varun

AU - Cobb, Dawayland

AU - Payne, Jennifer

AU - Meilman, Samantha

AU - Corwin, Elizabeth J.

AU - Kaminsky, Zachary A

AU - Dunlop, Anne L.

AU - Smith, Alicia K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Fetal intolerance of labor is a common indication for delivery by Caesarean section. Diagnosis is based on the presence of category III fetal heart rate tracing, which is an abnormal heart tracing associated with increased likelihood of fetal hypoxia and metabolic acidemia. This study analyzed data from 177 unique women who, during their prenatal visits (7-15 weeks and/or 24–32 weeks) to Atlanta area prenatal care clinics, consented to provide blood samples for DNA methylation (HumanMethylation450 BeadChip) and gene expression (Human HT-12 v4 Expression BeadChip) analyses. We focused on 57 women aged 18–36 (mean 25.4), who had DNA methylation data available from their second prenatal visit. DNA methylation patterns at CpG sites across the genome were interrogated for associations with fetal intolerance of labor. Four CpG sites (P value <8.9 × 10−9, FDR <0.05) in gene SLC9B1, a Na+/H+ exchanger, were associated with fetal intolerance of labor. DNA methylation and gene expression were negatively associated when examined longitudinally during pregnancy using a linear mixed-effects model. Positive predictive values of methylation of these four sites ranged from 0.80 to 0.89, while negative predictive values ranged from 0.91 to 0.92. The four CpG sites were also associated with fetal intolerance of labor in an independent cohort (the Johns Hopkins Prospective PPD cohort). Therefore, fetal intolerance of labor could be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation. Fetal intolerance of labor may be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation by assessing DNA methylation patterns of SLC9B1. The identification of pregnant women at elevated risk for fetal intolerance of labor may allow for the development of targeted treatments or management plans.

AB - Fetal intolerance of labor is a common indication for delivery by Caesarean section. Diagnosis is based on the presence of category III fetal heart rate tracing, which is an abnormal heart tracing associated with increased likelihood of fetal hypoxia and metabolic acidemia. This study analyzed data from 177 unique women who, during their prenatal visits (7-15 weeks and/or 24–32 weeks) to Atlanta area prenatal care clinics, consented to provide blood samples for DNA methylation (HumanMethylation450 BeadChip) and gene expression (Human HT-12 v4 Expression BeadChip) analyses. We focused on 57 women aged 18–36 (mean 25.4), who had DNA methylation data available from their second prenatal visit. DNA methylation patterns at CpG sites across the genome were interrogated for associations with fetal intolerance of labor. Four CpG sites (P value <8.9 × 10−9, FDR <0.05) in gene SLC9B1, a Na+/H+ exchanger, were associated with fetal intolerance of labor. DNA methylation and gene expression were negatively associated when examined longitudinally during pregnancy using a linear mixed-effects model. Positive predictive values of methylation of these four sites ranged from 0.80 to 0.89, while negative predictive values ranged from 0.91 to 0.92. The four CpG sites were also associated with fetal intolerance of labor in an independent cohort (the Johns Hopkins Prospective PPD cohort). Therefore, fetal intolerance of labor could be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation. Fetal intolerance of labor may be accurately predicted from maternal blood samples obtained between 24–32 weeks gestation by assessing DNA methylation patterns of SLC9B1. The identification of pregnant women at elevated risk for fetal intolerance of labor may allow for the development of targeted treatments or management plans.

KW - Biomarker, complication

KW - delivery

KW - fetal distress; NHEDC1; pregnancy; SLC9B1; sodium hydrogen exchanger

UR - http://www.scopus.com/inward/record.url?scp=85040964660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040964660&partnerID=8YFLogxK

U2 - 10.1080/15592294.2017.1411444

DO - 10.1080/15592294.2017.1411444

M3 - Article

C2 - 29235940

AN - SCOPUS:85040964660

SP - 1

EP - 7

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

ER -